A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease
Conditions: Non-alcoholic Fatty Liver Disease; Obesity Interventions: Drug: BI 3006337; Drug: Placebo matching BI 3006337 Sponsor: Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Eating Disorders & Weight Management | Fatty Liver Disease (FLD) | Liver | Liver Disease | Obesity | Research | Study | Urology & Nephrology